TNX-4300’s Mechanism of Restoring Neuroplasticity Supports Development as a First-in-Class Oral Therapy for Depression, Bipolar Disorder, Alzheimer’s Disease and Parkinson’s Disease
FDA approves first RSV vaccine
Drug makers have been racing at a breakneck pace to develop respiratory syncytial virus (RSV) vaccines this year. On May 3, the U.S. Food and Drug Administration (FDA) announced it has approved Arexvy, the first-ever RSV vaccine for individuals 60 and over.
Microbion Corp. Granted US Patent for the Use of Inhaled Pravibismane for Pulmonary Infections
Extends patent protection for Microbion’s proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039.
NIH Entrepreneurship News
Information on Small Business Funding Webinar, National Small Business Week, America’s SEED Fund Week — and more
UM Researcher Uses AI to Understand Lung Cancer Cell Vulnerabilities
A scientific team that includes University of Montana biologist Mark Grimes recently used artificial intelligence to better understand how protein groups in lung cancer cells regulate cell division and metabolism. The work may lead to greater understanding of lung cancer vulnerabilities and future anti-cancer therapies.
Nelson Labs Bozeman Announces GMP Viral Clearance Testing Service
Viral clearance testing is a critical step in the development and production of biologics and other products that are derived from biological sources. GMP-compliant service provides the assurance that products have been thoroughly tested for the presence of viral contaminants, and that they are safe for use.
Join the HERO Patients Registry
Scientists at the McLaughlin Institute are spearheading this patient registry which allows the Institute to enroll Montanans in potential clinical trials and research studies.
Three Tips for Scaling Biotech Companies in Montana
On January 12, 2023, the Montana High Tech Business Alliance and the Montana Bioscience Cluster Initiative co-hosted the webinar “Scaling Biotech Companies in Montana.” Panelists shared their insights into how companies can effectively plan for growth and how Montana can scale its biotech ecosystem.